SET DE REACTIVOS PARACREATINA QUINASA MB (CK-MB). - COFEPRIS Registration 262R2022 SSA
Access comprehensive regulatory information for SET DE REACTIVOS PARACREATINA QUINASA MB (CK-MB). (SET OF REAGENTS PARACREATINE KINASE MB (CK-MB).) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 262R2022 SSA and manufactured by DICIPA, S.A. DE C.V.. The device was registered on March 31, 2022.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
ELSETDEREACTIVOSPARACREATINAQUINASAMB(CK-MB)ESEMPLEADOPARALADETERMINACIÓNCUANTITATIVADELA ACTIVIDAD DE CREATINA QUINASA PRESENTE EN ELSUERO.PARAUSOEXCLUSIVODELABORATORIOSCLÍNICOSO DE GABINETE. AGENTES DE DIAGNÓSTICO IN VITRO.
THE SET OF REAGENTS FOR CREATINE KINASAMB (CK-MB) IS USED FOR THE QUANTITATIVE DETERMINATION OF THE ACTIVITY OF CREATINE KINASE PRESENT IN SERUM. FOR THE EXCLUSIVE USE OF CLINICAL OR OFFICE LABORATORIES. IN VITRO DIAGNOSTIC AGENTS.